Table 3.

Patients with heterogeneous responses to nivolumab.

	Intrahepatic tumor		Extrahepatic tumor−1			Extrahepatic tumor−2			Overall response
Pt.	Size (cm)	Response	Location	Size (cm)	Response	Location	Size (cm)	Response
#1	No tumor		Lung	4.2	10% ↑	Lung	2.6	60% ↓	PR
#2	No tumor		Peritoneum	4.3	13% ↑	Lung	1.2	80% ↓	PR
#3	1.4	5%↓	Lung	1.8	10% ↑	Lung	1.2	30% ↓	SD
#4	3.3	100% ↑	Lung	1.2	70% ↓	Lung	1	80% ↓	SD
#5	3.3	25%↓	Peritoneum	1.0	200%↑	Lung	1	100%↑	PD
#6	7.2	5% ↑	Lung	2.1	55% ↓	Lung	1.9	62% ↓	PR

PD, progressive disease; PR, partial response; SD, stable disease.